Skip to main content
. Author manuscript; available in PMC: 2012 Aug 25.
Published in final edited form as: J Med Chem. 2011 Jul 20;54(16):5858–5867. doi: 10.1021/jm200591t

Table 1.

Receptor Affinities and Fluorescence Properties of Final Compounds

graphic file with name nihms312894u1.jpg
Ki nMa CHCl3 EtOHb PBSb,c

comp X Y Z σ1 σ2 λexc nm λem nm Φ λexc nm λem nm Φ λexc nm λem nm εd
1e CH3 CH2 0.38±0.10 0.68±0.20
7 CH3 A CH2CH2 2570f 1720±160 450 515 0.17 476 520 0.08 480 535 14391
8 CH3 B CH2CH2 >5000f 5020±180 346 490 0.32 335 507 0.29 340 510 2600
16 A CH2 CH2CH2 78.7±18.2 10.8±3.0 451 514 0.20 467 520 0.05 460 520 11300
17 A CH2 O 96.2f 39.3±11.8 450 512 0.18 465 520 0.04 460 520 6544
18 B CH2 CH2CH2 9.08±1.32 20.8±1.5 340 490 0.30 335 507 0.20 345 485 4000
19 B CH2 O 19.8±8.7 25.7±4.7 345 490 0.48 335 507 0.23 343 510 2741

(+)-pentazocine 2.62±0.25
DTG 24.6±2.2
a

Values are the means of n ≥ 2 separate experiments.

b

Fluorescence properties herein reported were evaluated on compounds as free bases, but they were also evaluated on their corresponding hydrochloride salts in EtOH and PBS solutions. A maximum of 5 nm shift was observed in the excitation and emission wavelengths when compared to the excitation and emission wavelengths from the corresponding free bases.

c

All compounds solubilized in PBS gave Φ̣ value very close to 0 and therefore they are not reported.

d

From EtOH solutions of compounds in EtOH.

e

From Ref 18 where results from binding on human cells, in which compound 1 displays about 40-fold σ2 versus σ1 selectivity, are also reported.

f

From a unique experiment.